论文信息 - ATLAS: A phase II open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma (mUC). - 字舞流文

ATLAS: A phase II open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma (mUC).

S. Srinivas | A. Alva | D. Josephs | N. Vogelzang | A. Necchi | Y. Zakharia | P. Grivas | Sumati Gupta | Y. Loriot | S. Chowdhury | R. Dusek | S. Feyerabend | A. Simmons | K. Wride | A. Rodríguez-Vida | D. Thomas | D. Nepert